The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms

Ítems similars

• Bone marrow niche dysregulation in myeloproliferative neoplasms
  per: Natalia Curto-Garcia, et al.
  Publicat: (2020-05-01)
• Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms
  per: Naoimh Herlihy, et al.
  Publicat: (2019-04-01)
• Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib
  per: Bridget S. Wilkins, et al.
  Publicat: (2013-12-01)
• Pathophysiology of thrombosis in myeloproliferative neoplasms
  per: Raffaele Landolfi, et al.
  Publicat: (2011-02-01)
• Modification of the histone landscape with JAK inhibition in myeloproliferative neoplasms
  per: Greenfield, G, et al.
  Publicat: (2020)